GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.41 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 90,000 | $295,200 | 0.31% |
| Greenlight Capital | 588,410 | $1,929,985 | 0.11% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $190,568 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,100 | $148,903 | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 2,500 | $8,200 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HM PAYSON & CO | 1,000 | $3,280 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,937 | $6,257 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 151,476 | $489,355 | 0.00% |
| MORGAN STANLEY | 1,300 | $4,264 | 0.00% |